Chen Y - Search Results

1

Immune-Checkpoint Inhibitors as the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.

Chen Y, Zhou Y, Tang L, Peng X, Jiang H, Wang G, Zhuang W. Chen Y, et al. J Cancer. 2019 Oct 17;10(25):6261-6268. doi: 10.7150/jca.34677. eCollection 2019. J Cancer. 2019. PMID: 31772659 Free PMC article. Review.

2

Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis.

Chen Y, Peng X, Zhou Y, Xia K, Zhuang W. Chen Y, et al. World J Surg Oncol. 2018 Jan 16;16(1):8. doi: 10.1186/s12957-018-1313-x. World J Surg Oncol. 2018. PMID: 29338734 Free PMC article. Review.

3

A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer.

Chen Y, Mao B, Peng X, Zhou Y, Xia K, Guo H, Jiang H, Wang G, Zhuang W. Chen Y, et al. J Cancer. 2019 Mar 3;10(7):1642-1650. doi: 10.7150/jca.28266. eCollection 2019. J Cancer. 2019. PMID: 31205520 Free PMC article.

4

Transcriptional Characterization Of The Tumor Immune Microenvironment And Its Prognostic Value For Locally Advanced Lung Adenocarcinoma In A Chinese Population.

Chen Y, Chen H, Mao B, Zhou Y, Shi X, Tang L, Jiang H, Wang G, Zhuang W. Chen Y, et al. Among authors: chen h. Cancer Manag Res. 2019 Oct 31;11:9165-9173. doi: 10.2147/CMAR.S209571. eCollection 2019. Cancer Manag Res. 2019. PMID: 31802941 Free PMC article.

5

Reduced LINC00551 expression promotes proliferation and invasion of esophageal squamous cancer by increase in HSP27 phosphorylation.

Peng X, Zhou Y, Chen Y, Tang L, Wang G, Jiang H, Wang X, Tao Y, Zhuang W. Peng X, et al. Among authors: chen y. J Cell Physiol. 2021 Feb;236(2):1418-1431. doi: 10.1002/jcp.29947. Epub 2020 Jul 17. J Cell Physiol. 2021. PMID: 32677057

6

Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis.

Tang L, Chen Y, Peng X, Zhou Y, Jiang H, Wang G, Zhuang W. Tang L, et al. Among authors: chen y. Front Genet. 2020 Dec 10;11:521004. doi: 10.3389/fgene.2020.521004. eCollection 2020. Front Genet. 2020. PMID: 33362844 Free PMC article.

7

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment.

Zhou Y, Tang L, Chen Y, Zhang Y, Zhuang W. Zhou Y, et al. Among authors: chen y. Front Cell Dev Biol. 2021 Dec 21;9:797984. doi: 10.3389/fcell.2021.797984. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34993203 Free PMC article.

8

Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.

Long S, Chen Y, Wang Y, Yao Y, Xiao S, Fu K. Long S, et al. Among authors: chen y. Cancer Med. 2023 Jan;12(2):2134-2147. doi: 10.1002/cam4.5032. Epub 2022 Jul 16. Cancer Med. 2023. PMID: 35841206 Free PMC article.

9

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.

Chen Y, Tang L, Huang W, Zhang Y, Abisola FH, Li L. Chen Y, et al. Front Endocrinol (Lausanne). 2022 Oct 24;13:963220. doi: 10.3389/fendo.2022.963220. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353226 Free PMC article.

10

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.

Chen Y, Tang L, Huang W, Abisola FH, Zhang Y, Zhang G, Yao L. Chen Y, et al. Biol Direct. 2023 Feb 7;18(1):4. doi: 10.1186/s13062-023-00358-w. Biol Direct. 2023. PMID: 36750831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176,594 results

Search Page

Filters